Effects of GLP-1 receptor agonists and SGLT-2 inhibitors in heart transplant patients with type 2 diabetes: Initial report from a cardiometabolic center of excellence
Yasser Sammour, Michael E. Nassif, Melissa Magwire, Merrill Thomas, Timothy J. Fendler, Taiyeb Khumri, Brett W. Sperry, James H. O’Keefe, Mikhail Kosiborod
Topics & Concepts
MedicineType 2 diabetesLiraglutideDiscontinuationDiabetes mellitusGlucagon-like peptide 1 receptorType 2 Diabetes MellitusAdverse effectInternal medicineHeart transplantationTransplantationEndocrinologyReceptorAgonistDiabetes Treatment and ManagementTransplantation: Methods and OutcomesAdenosine and Purinergic Signaling